Nicholas Conrad Smith is President & CFO at Alto Neuroscience, Inc. (ANRO). They have made 2 open-market trades across 1 company since 2024, most recently 2026-10-02.
CIK 0002009130
2 open-market purchases totalling $126K since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ANRO | 79,060 | $1.7M |
Shares reported on the most recent Form 4, priced at the 2026-10-05 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.